VJHemOnc Podcast

iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies

May 11, 2023
World-leading experts in CAR-T therapy discuss updates on CAR-T therapy in lymphoma, including efficacy, durability of response, and real-world experience. They also discuss the potential role of bispecific antibodies, challenges related to patient access and manufacturing, and potential strategies in treating CAR-T therapy resistance.
Ask episode
Chapters
Transcript
Episode notes